Clinical Trial Update: Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Chinese Men and Postmenopausal Women With Advanced Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update describes an ongoing study evaluating alpelisib plus fulvestrant versus placebo plus fulvestrant in Chinese men and postmenopaus…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Faslodex (fulvestrant)
• Piqray (alpelisib)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Breast Neoplasms | Phase 2 | Status: ACTIVE_NOT_RECRUITING